Newly Recognized Ocular Side Effects of Erlotinib
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology,General Medicine,Surgery
Reference5 articles.
1. Current management of advanced non-small cell lung cancer: targeted therapy.;Isobe;Semin Oncol,2005
2. Epidermal growth factor receptor inhibition strategies in oncology.;Harari;Endocr Relat Cancer,2004
3. Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?;Perez-Soler;J Clin Oncol,2005
4. Differences in human skin between the epidermal growth factor receptor distribution detected by EGF binding and monoclonal antibody recognition.;Green;J Invest Dermatol,1985
5. Imatinib treatment: specific issues related to safety, fertility, and pregnancy.;Hensley;Semin Hematol,2003
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Adverse effects of anti-cancer biologics on the ocular surface;Current Opinion in Allergy & Clinical Immunology;2024-07-04
2. Panitumumab-Induced Periorbital Dermatitis: A Case Report;Clinical, Cosmetic and Investigational Dermatology;2024-04
3. Erlotinib-induced dry eye;Indian Journal of Ophthalmology;2023-04
4. Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein–Expressing Non–Small-Cell Lung Cancer;Journal of Clinical Oncology;2023-02-10
5. Emergence of ocular toxicities associated with novel anticancer therapeutics: What the oncologist needs to know;Cancer Treatment Reviews;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3